NIDA Acknowledges Drawbacks to Monopoly on Marijuana Supply

WASHINGTON, DC — Members of the US Senate at a hearing Wednesday expressed skepticism in regard to federal policies limiting the ability of investigators to engage in clinical studies of marijuana’s health benefits. Senators heard from representatives from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), National Institute on Drug Abuse (NIDA), University of […]